Accuryn Medical Announces Leadership Transition

2024-04-17

高管变更

Rich Keenan and Sanjay Banerjee Named Co-CEOs HAYWARD, CA / ACCESSWIRE / April 17, 2024 / Accuryn Medical, innovator of the Accuryn Monitoring System, a device designed to monitor the kidney, reduce the risks associated with catheter-associated urinary tract infections and streamline nurse workflow, announced a significant leadership transition. After a successful tenure, Joe Urban will be stepping down from his role as CEO. With Joe's departure, the Board of Directors is pleased to announce Rich Keenan and Sanjay Banerjee as the company's new Co-Chief Executive Officers. Rich Keenan brings a wealth of experience to his new position, having dedicated 10 years to Accuryn's growth and development. His profound understanding of the company's vision and his pivotal role as the primary engineer behind Accuryn's groundbreaking technology make him an ideal candidate for this leadership role. Sanjay Banerjee, previously serving as the Chief Operating Officer, steps into his new role as Co-CEO with a proven track record of operational excellence and strategic leadership. His deep understanding of Accuryn's operations and his commitment to driving innovation and efficiency make him an invaluable addition to the executive team. Together, Rich and Sanjay will lead Accuryn Medical into its next phase of growth and expansion, leveraging their combined expertise to drive innovation, deliver exceptional value to customers, and propel the company towards continued success. "We are excited to embark on this new chapter for Accuryn Medical," said Rich Keenan and Sanjay Banerjee, Co-CEOs of Accuryn Medical. "We are committed to building upon the strong foundation laid by our predecessors and steering the company towards even greater achievements. With a shared vision for innovation and a dedication to improving patient outcomes, we look forward to leading Accuryn to new heights." Accuryn Medical expresses its gratitude to Joe Urban for his leadership and contributions to the company during his tenure as CEO. His guidance and vision have been instrumental in shaping Accuryn's success, and the company wishes him all the best in his future endeavors. About Accuryn Medical Accuryn Medical, Inc. is committed to addressing Acute Kidney Injury (AKI) through real-time renal assessment with the Accuryn Monitoring System, which enables early intervention of AKI to reduce preventable mortality and morbidity. The platform technology provides an automated, accurate and consistent flow of data and enables a predictive algorithm for the early detection and treatment of this disease. Accuryn Medical is headquartered in Hayward, CA. For more information, visit . Contact Information Myria Crawford VP Marketing mcrawford@accuryn.com 888.635.7280 Sanjay Banerjee co-CEO sbanerjee@accuryn.com 888.635.7280 Rich Keenan co-CEO rkeenan@accuryn.com 888.635.7280 SOURCE: Accuryn Medical View the original press release on newswire.com.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构